Infectious Disease Clinics of North America volume 18, issue 4, P939-962 2004 DOI: 10.1016/j.idc.2004.08.001 View full text
|
|
Share
Donald E. Craven, Richard Palladino, Daniel P. McQuillen

Abstract: Guidelines for Management of HAP were developed jointly by the ATS and IDSA in 2004. These guidelines were designed to improve patient outcomes and to decrease the emergence of MDR pathogens (see Fig. 1).Principles include early initiation of appropriate and adequate antibiotic therapy after cultures of blood and sputum are obtained. Quantitative distal airway sampling by bronchoscopy provides greater diagnostic specificity for VAP: in one randomized study, improved outcomes were noted, compared with clinical …

expand abstract